Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

Current management of Barrett esophagus and esophageal adenocarcinoma.

Singh T, Sanghi V, Thota PN.

Cleve Clin J Med. 2019 Nov;86(11):724-732. doi: 10.3949/ccjm.86a.18106. Review.

2.

Obesity Does Not Impact Outcomes or Rates of Gastroesophageal Reflux After Peroral Endoscopic Myotomy in Achalasia.

Sanaka MR, Parikh MP, Subramanium S, Thota PN, Gupta NM, Lopez R, Gabbard S, Murthy S, Raja S.

J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001235. [Epub ahead of print]

PMID:
31306345
3.

Outcomes of endoscopic submucosal dissection in esophageal adenocarcinoma staged T1bN0 by endoscopic ultrasound in non-surgical patients.

Parikh MP, Thota PN, Raja S, Murthy S, Ahmad U, Gupta NM, Sanaka MR.

J Gastrointest Oncol. 2019 Apr;10(2):362-366. doi: 10.21037/jgo.2018.07.12.

4.

Barrett's esophagus: novel strategies for screening and surveillance.

Sanghi V, Thota PN.

Ther Adv Chronic Dis. 2019 Mar 26;10:2040622319837851. doi: 10.1177/2040622319837851. eCollection 2019. Review.

5.

Proposal of high-risk adenoma detection rate as an impactful, complementary quality indicator of colonoscopy.

Wadhwa V, Jobanputra Y, Al Taii H, Thota PN, Lopez R, Gurudu SR, Sanaka MR.

Surg Endosc. 2019 Mar 29. doi: 10.1007/s00464-019-06770-6. [Epub ahead of print]

PMID:
30927122
6.

Clinical Outcomes Based on the Timing of Appearance of Visible Lesions in Barrett's Esophagus During Endoscopic Eradication Therapy.

Thota PN, Benjamin T, Sanaka MR, Goldblum JR, Vargo J, Jang S, Lopez R.

J Clin Gastroenterol. 2019 Jan 4. doi: 10.1097/MCG.0000000000001165. [Epub ahead of print]

PMID:
30614938
7.

Cryotherapy in the management of premalignant and malignant conditions of the esophagus.

Lal P, Thota PN.

World J Gastroenterol. 2018 Nov 21;24(43):4862-4869. doi: 10.3748/wjg.v24.i43.4862. Review.

8.

Reintervention After Heller Myotomy for Achalasia: Is It Inevitable?

Raja S, Schraufnagel DP, Blackstone EH, Murthy SC, Thota PN, Thuita L, Lopez R, Gabbard SL, Ray MN, Wadhwa N, Sanaka MR, Zanoni A, Rice TW.

Ann Thorac Surg. 2019 Mar;107(3):860-867. doi: 10.1016/j.athoracsur.2018.09.059. Epub 2018 Nov 10.

PMID:
30423334
9.

Peroral endoscopic myotomy leads to higher rates of abnormal esophageal acid exposure than laparoscopic Heller myotomy in achalasia.

Sanaka MR, Thota PN, Parikh MP, Hayat U, Gupta NM, Gabbard S, Lopez R, Murthy S, Raja S.

Surg Endosc. 2019 Jul;33(7):2284-2292. doi: 10.1007/s00464-018-6522-4. Epub 2018 Oct 19.

PMID:
30341655
10.

Endoscopic therapy for Barrett's esophagus and early esophageal cancer: Where do we go from here?

Singh T, Sanaka MR, Thota PN.

World J Gastrointest Endosc. 2018 Sep 16;10(9):165-174. doi: 10.4253/wjge.v10.i9.165. Review.

11.

Is Mass Screening for Barrett's Esophagus a Myth or Reality?

Thota PN, Chak A.

Clin Gastroenterol Hepatol. 2019 Mar;17(4):610-612. doi: 10.1016/j.cgh.2018.09.026. Epub 2018 Sep 26. No abstract available.

12.

Metastatic lung adenocarcinoma presenting as diminutive colonic polyp.

Thota PN, Plesec T.

AME Case Rep. 2018 Apr 18;2:14. doi: 10.21037/acr.2018.03.06. eCollection 2018. No abstract available.

13.

Role of endoscopic therapy in early esophageal cancer.

Malik S, Sharma G, Sanaka MR, Thota PN.

World J Gastroenterol. 2018 Sep 21;24(35):3965-3973. doi: 10.3748/wjg.v24.i35.3965.

14.

Peroral Endoscopic Myotomy Is Effective for Patients With Achalasia and Normal Lower-Esophageal Sphincter Relaxation Pressures.

Sanaka MR, Parikh MP, Thota PN, Gupta NM, Gabbard S, Lopez R, Murthy S, Raja S.

Clin Gastroenterol Hepatol. 2018 Aug 25. pii: S1542-3565(18)30898-X. doi: 10.1016/j.cgh.2018.08.059. [Epub ahead of print]

PMID:
30153516
15.

Gender, medication use and other factors associated with esophageal motility disorders in non-obstructive dysphagia.

Kamal A, Shakya S, Lopez R, Thota PN.

Gastroenterol Rep (Oxf). 2018 Aug;6(3):177-183. doi: 10.1093/gastro/goy018. Epub 2018 Jun 2.

16.

Lower Annual Rate of Progression of Short-Segment vs Long-Segment Barrett's Esophagus to Esophageal Adenocarcinoma.

Hamade N, Vennelaganti S, Parasa S, Vennalaganti P, Gaddam S, Spaander MCW, van Olphen SH, Thota PN, Kennedy KF, Bruno MJ, Vargo JJ, Mathur S, Cash BD, Sampliner R, Gupta N, Falk GW, Bansal A, Young PE, Lieberman DA, Sharma P.

Clin Gastroenterol Hepatol. 2019 Apr;17(5):864-868. doi: 10.1016/j.cgh.2018.07.008. Epub 2018 Aug 8.

PMID:
30012433
17.

Factors predictive of gastroesophageal reflux disease and esophageal motility disorders in patients with non-cardiac chest pain.

Gomez Cifuentes J, Lopez R, Thota PN.

Scand J Gastroenterol. 2018 Jun;53(6):643-649. doi: 10.1080/00365521.2018.1452975. Epub 2018 May 30.

PMID:
29848163
18.

Lower prevalence of gastroesophageal reflux disease in patients with noncardiac chest pain on opiates: a cross-sectional study.

Cifuentes JDG, Thota PN, Lopez R.

Dis Esophagus. 2018 Nov 1;31(11). doi: 10.1093/dote/doy053.

PMID:
29846541
19.

Aspirin: the miracle drug?

Thota PN.

Clin Transl Gastroenterol. 2018 May 2;9(5):153. doi: 10.1038/s41424-018-0009-4.

20.

Value of routine timed barium esophagram follow-up in achalasia after myotomy.

Kachala SS, Rice TW, Baker ME, Rajeswaran J, Thota PN, Murthy SC, Blackstone EH, Zanoni A, Raja S.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):871-877.e2. doi: 10.1016/j.jtcvs.2018.03.001. Epub 2018 Mar 8.

PMID:
29627183
21.

Inpatient burden of esophageal cancer and analysis of factors affecting in-hospital mortality and length of stay.

Sarvepalli S, Garg SK, Sarvepalli SS, Parikh MP, Wadhwa V, Jang S, Thota PN, Sanaka MR.

Dis Esophagus. 2018 Sep 1;31(9). doi: 10.1093/dote/doy022.

PMID:
29617798
22.

Association of sporadic and familial Barrett's esophagus with breast cancer.

Chan MQ, Blum AE, Chandar AK, Emmons AMLK, Shindo Y, Brock W, Falk GW, Canto MI, Wang JS, Iyer PG, Shaheen NJ, Grady WM, Abrams JA, Thota PN, Guda KK, Chak A.

Dis Esophagus. 2018 Apr 1;31(4). doi: 10.1093/dote/doy007.

23.

Cryotherapy and Radiofrequency Ablation for Eradication of Barrett's Esophagus with Dysplasia or Intramucosal Cancer.

Thota PN, Arora Z, Dumot JA, Falk G, Benjamin T, Goldblum J, Jang S, Lopez R, Vargo JJ.

Dig Dis Sci. 2018 May;63(5):1311-1319. doi: 10.1007/s10620-018-5009-4. Epub 2018 Mar 9.

PMID:
29524114
24.

Hospital Utilization in Patients With Gastric Cancer and Factors Affecting In-Hospital Mortality, Length of Stay, and Costs.

Sarvepalli S, Garg SK, Sarvepalli SS, Anugwom C, Wadhwa V, Thota PN, Sanaka MR.

J Clin Gastroenterol. 2019 Apr;53(4):e157-e163. doi: 10.1097/MCG.0000000000001016.

PMID:
29517707
25.

Proximal Sessile Serrated Adenomas Are More Prevalent in Caucasians, and Gastroenterologists Are Better Than Nongastroenterologists at Their Detection.

Parikh MP, Muthukuru S, Jobanputra Y, Naha K, Gupta NM, Wadhwa V, Lopez R, Thota PN, Sanaka MR.

Gastroenterol Res Pract. 2017;2017:6710931. doi: 10.1155/2017/6710931. Epub 2017 Dec 18.

26.

Vitamin D in esophageal cancer: Is there a role for chemoprevention?

Rouphael C, Kamal A, Sanaka MR, Thota PN.

World J Gastrointest Oncol. 2018 Jan 15;10(1):23-30. doi: 10.4251/wjgo.v10.i1.23. Review.

27.

Outcomes Associated With Timing of ERCP in Acute Cholangitis Secondary to Choledocholithiasis.

Parikh MP, Wadhwa V, Thota PN, Lopez R, Sanaka MR.

J Clin Gastroenterol. 2018 Nov/Dec;52(10):e97-e102. doi: 10.1097/MCG.0000000000000982.

PMID:
29356786
28.

Identifying DNA methylation biomarkers for non-endoscopic detection of Barrett's esophagus.

Moinova HR, LaFramboise T, Lutterbaugh JD, Chandar AK, Dumot J, Faulx A, Brock W, De la Cruz Cabrera O, Guda K, Barnholtz-Sloan JS, Iyer PG, Canto MI, Wang JS, Shaheen NJ, Thota PN, Willis JE, Chak A, Markowitz SD.

Sci Transl Med. 2018 Jan 17;10(424). pii: eaao5848. doi: 10.1126/scitranslmed.aao5848.

29.

Endoscopic Treatments of GERD.

Rouphael C, Padival R, Sanaka MR, Thota PN.

Curr Treat Options Gastroenterol. 2018 Mar;16(1):58-71. doi: 10.1007/s11938-018-0170-6. Review.

PMID:
29340935
30.

Erratum: Use of a Novel Submucosal Tunneling and Endoscopic Resection (STER) Technique for the Removal of an Esophageal Leiomyoma.

Sanaka MR, Parikh MP, Thota PN, Gupta NM, Raja S.

Am J Gastroenterol. 2018 Jan;113(1):154. doi: 10.1038/ajg.2017.427.

PMID:
29311722
31.

Genomic regions associated with susceptibility to Barrett's esophagus and esophageal adenocarcinoma in African Americans: The cross BETRNet admixture study.

Sun X, Chandar AK, Canto MI, Thota PN, Brock M, Shaheen NJ, Beer DG, Wang JS, Falk GW, Iyer PG, Abrams JA, Venkat-Ramani M, Veigl M, Miron A, Willis J, Patil DT, Nalbantoglu I, Guda K, Markowitz SD, Zhu X, Elston R, Chak A.

PLoS One. 2017 Oct 26;12(10):e0184962. doi: 10.1371/journal.pone.0184962. eCollection 2017.

32.

Identification of a key role of widespread epigenetic drift in Barrett's esophagus and esophageal adenocarcinoma.

Luebeck EG, Curtius K, Hazelton WD, Maden S, Yu M, Thota PN, Patil DT, Chak A, Willis JE, Grady WM.

Clin Epigenetics. 2017 Oct 16;9:113. doi: 10.1186/s13148-017-0409-4. eCollection 2017.

33.

A nonrandomized trial of vitamin D supplementation for Barrett's esophagus.

Cummings LC, Thota PN, Willis JE, Chen Y, Cooper GS, Furey N, Bednarchik B, Alashkar BM, Dumot J, Faulx AL, Fink SP, Kresak AM, Abusneineh B, Barnholtz-Sloan J, Leahy P, Veigl ML, Chak A, Markowitz SD.

PLoS One. 2017 Sep 18;12(9):e0184928. doi: 10.1371/journal.pone.0184928. eCollection 2017.

34.

Temporal trends in utilization and outcomes of endoscopic retrograde cholangiopancreatography in acute cholangitis due to choledocholithiasis from 1998 to 2012.

Parikh MP, Gupta NM, Thota PN, Lopez R, Sanaka MR.

Surg Endosc. 2018 Apr;32(4):1740-1748. doi: 10.1007/s00464-017-5856-7. Epub 2017 Sep 15.

PMID:
28917018
35.

A randomized double-blind placebo-controlled crossover-style trial of buspirone in functional dysphagia and ineffective esophageal motility.

Aggarwal N, Thota PN, Lopez R, Gabbard S.

Neurogastroenterol Motil. 2018 Feb;30(2). doi: 10.1111/nmo.13213. Epub 2017 Sep 8.

PMID:
28884884
36.

Spectrum of esophageal dysmotility in systemic sclerosis on high-resolution esophageal manometry as defined by Chicago classification.

Aggarwal N, Lopez R, Gabbard S, Wadhwa N, Devaki P, Thota PN.

Dis Esophagus. 2017 Dec 1;30(12):1-6. doi: 10.1093/dote/dox067.

PMID:
28881879
37.

Reply to multiregional dysmotility in diabetes mellitus assessed using the wireless motility capsule.

Rouphael C, Thota PN, Cline M.

Neurogastroenterol Motil. 2017 Sep;29(9). doi: 10.1111/nmo.13147. No abstract available.

PMID:
28782195
38.

Use of a Novel Submucosal Tunneling and Endoscopic Resection (STER) Technique for the Removal of an Esophageal Leiomyoma.

Sanaka MR, Parikh MP, Thota PN, Gupta NM, Raja S.

Am J Gastroenterol. 2017 Jul;111(12):986. doi: 10.1038/ajg.2017.168. No abstract available. Erratum in: Am J Gastroenterol. 2018 Jan;113(1):154.

PMID:
28725059
39.

Achalasia: current therapeutic options.

Arora Z, Thota PN, Sanaka MR.

Ther Adv Chronic Dis. 2017 Jun;8(6-7):101-108. doi: 10.1177/2040622317710010. Epub 2017 Jun 23. Review.

40.

Healthcare utilization and costs associated with gastroparesis.

Wadhwa V, Mehta D, Jobanputra Y, Lopez R, Thota PN, Sanaka MR.

World J Gastroenterol. 2017 Jun 28;23(24):4428-4436. doi: 10.3748/wjg.v23.i24.4428.

41.

Risk of progression of Barrett's esophagus in patients with cirrhosis.

Apfel T, Lopez R, Sanaka MR, Thota PN.

World J Gastroenterol. 2017 May 14;23(18):3287-3294. doi: 10.3748/wjg.v23.i18.3287.

42.

Changing Trends in Age, Gender, Racial Distribution and Inpatient Burden of Achalasia.

Wadhwa V, Thota PN, Parikh MP, Lopez R, Sanaka MR.

Gastroenterology Res. 2017 Apr;10(2):70-77. doi: 10.14740/gr723w. Epub 2017 Apr 19.

43.

Upper esophageal sphincter abnormalities and high-resolution esophageal manometry findings in patients with laryngopharyngeal reflux.

Benjamin T, Zackria S, Lopez R, Richter J, Thota PN.

Scand J Gastroenterol. 2017 Aug;52(8):816-821. doi: 10.1080/00365521.2017.1322139. Epub 2017 May 4.

PMID:
28471304
44.

Role of wireless motility capsule in the assessment and management of gastrointestinal dysmotility in patients with diabetes mellitus.

Rouphael C, Arora Z, Thota PN, Lopez R, Santisi J, Funk C, Cline M.

Neurogastroenterol Motil. 2017 Sep;29(9). doi: 10.1111/nmo.13087. Epub 2017 Apr 26.

PMID:
28444862
45.

Lymphocytic esophagitis: Still an enigma a decade later.

Rouphael C, Gordon IO, Thota PN.

World J Gastroenterol. 2017 Feb 14;23(6):949-956. doi: 10.3748/wjg.v23.i6.949. Review.

46.

Lack of incremental effect of histamine receptor antagonists over proton pump inhibitors on the risk of neoplastic progression in patients with Barrett's esophagus: a cohort study.

Thota PN, Hajifathalian K, Benjamin T, Runkana A, Lopez R, Sanaka MR.

J Dig Dis. 2017 Mar;18(3):143-150. doi: 10.1111/1751-2980.12457.

PMID:
28188977
47.

Multiple recurrences of esophageal adenocarcinoma after esophagectomy.

Benjamin T, Shakya S, Thota PN.

Transl Gastroenterol Hepatol. 2016 Oct 26;1:79. doi: 10.21037/tgh.2016.09.09. eCollection 2016. No abstract available.

48.

Low Risk of High-Grade Dysplasia or Esophageal Adenocarcinoma Among Patients With Barrett's Esophagus Less Than 1 cm (Irregular Z Line) Within 5 Years of Index Endoscopy.

Thota PN, Vennalaganti P, Vennelaganti S, Young P, Gaddam S, Gupta N, Lieberman D, Sampliner R, Falk GW, Mathur S, Kennedy K, Cash BD, Moawad F, Bansal A, Spaander MC, Bruno MJ, Vargo J, Sharma P.

Gastroenterology. 2017 Apr;152(5):987-992. doi: 10.1053/j.gastro.2016.12.005. Epub 2016 Dec 15.

PMID:
27988383
49.

Synchronous or Metachronous Occurrence of Lesions of Different Histologic Types in Patients With Esophageal Cancer.

Benjamin T, Thota PN.

Clin Gastroenterol Hepatol. 2017 May;15(5):780-781. doi: 10.1016/j.cgh.2016.11.031. Epub 2016 Dec 5. No abstract available.

PMID:
27932300
50.

Feasibility of volumetric laser endomicroscopy in Barrett's esophagus with dysplasia and in post-ablation surveillance.

Benjamin T, Shakya S, Thota PN.

J Gastrointestin Liver Dis. 2016 Sep;25(3):407-8. doi: 10.15403/jgld.2014.1121.253.brt. No abstract available.

Supplemental Content

Loading ...
Support Center